Additionally, the elevated levels of soluble CD40L found in both bipolar disorder and SZ indicate the change in the inflammatory system (36), which suggests that activating the CD40 signaling pathway could trigger the release of anti-inflammatory cytokines and neuroprotective factors, potentially slowing the development and progression of SZ. This evidence concerns the gene CD40 and bipolar disorder.